Rasmus Jorgensen (Novo Nordisk A/S, Denmark)
Using BRET to monitor receptor interactions with downstream signaling partners – examples for GLP-1 and insulin receptors

请使用IE浏览器访问播放 

     苹果系统用户点击此处播放